These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16893613)

  • 21. Effect of L-NAME-induced hypertension on melatonin receptors and melatonin levels in the pineal gland and the peripheral organs of rats.
    Benova M; Herichova I; Stebelova K; Paulis L; Krajcirovicova K; Simko F; Zeman M
    Hypertens Res; 2009 Apr; 32(4):242-7. PubMed ID: 19262491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding.
    Sugimoto Y; Kajiwara Y; Hirano K; Yamada S; Tagawa N; Kobayashi Y; Hotta Y; Yamada J
    Eur J Pharmacol; 2008 Sep; 592(1-3):116-22. PubMed ID: 18655786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Methylphenidate augmentation of fluvoxamine for treatment-resistant depression: a case report and review literature].
    Buhagiar K; Cassar J
    Turk Psikiyatri Derg; 2007; 18(2):179-83. PubMed ID: 17566884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance.
    Tan DX; Manchester LC; Terron MP; Flores LJ; Tamura H; Reiter RJ
    J Pineal Res; 2007 Nov; 43(4):317-20. PubMed ID: 17910598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ramelteon for the treatment of insomnia.
    Borja NL; Daniel KL
    Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluvoxamine therapy for fibromyalgia.
    Nishikai M; Akiya K
    J Rheumatol; 2003 May; 30(5):1124. PubMed ID: 12734926
    [No Abstract]   [Full Text] [Related]  

  • 27. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy of imipramine and melatonin: additive antidepressant effect in mouse forced swimming test.
    Ergün Y; Orhan FO; Karaaslan MF
    Eur J Pharmacol; 2008 Sep; 591(1-3):159-63. PubMed ID: 18601918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin, shedding new light on darkness.
    Miskovitz P
    Crit Care Med; 2008 Jan; 36(1):333-4. PubMed ID: 18158442
    [No Abstract]   [Full Text] [Related]  

  • 30. Rapid and sensitive bioanalytical method for measurement of fluvoxamine in human serum using 4-chloro-7-nitrobenzofurazan as pre-column derivatization agent: application to a human pharmacokinetic study.
    Bahrami G; Mohammadi B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):322-6. PubMed ID: 17704014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antineoplastic effects of melatonin on a rare malignancy of mesenchymal origin: melatonin receptor-mediated inhibition of signal transduction, linoleic acid metabolism and growth in tissue-isolated human leiomyosarcoma xenografts.
    Dauchy RT; Blask DE; Dauchy EM; Davidson LK; Tirrell PC; Greene MW; Tirrell RP; Hill CR; Sauer LA
    J Pineal Res; 2009 Aug; 47(1):32-42. PubMed ID: 19486272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin decreases nitric oxide production and lipid peroxidation and increases interleukin-1 beta in the brain of mice infected by the Venezuelan equine encephalomyelitis virus.
    Valero N; MarinaEspina L; Bonilla E; Mosquera J
    J Pineal Res; 2007 Mar; 42(2):107-12. PubMed ID: 17286740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melatonin receptors mediate improvements of liver function but not of hepatic perfusion and integrity after hemorrhagic shock in rats.
    Mathes AM; Kubulus D; Weiler J; Bentley A; Waibel L; Wolf B; Bauer I; Rensing H
    Crit Care Med; 2008 Jan; 36(1):24-9. PubMed ID: 18090374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors.
    Dinan TG; Clarke G; Quigley EM; Scott LV; Shanahan F; Cryan J; Cooney J; Keeling PW
    Am J Gastroenterol; 2008 Oct; 103(10):2570-6. PubMed ID: 18785949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered basal and postprandial plasma melatonin, gastrin, ghrelin, leptin and insulin in patients with liver cirrhosis and portal hypertension without and with oral administration of melatonin or tryptophan.
    Celinski K; Konturek PC; Slomka M; Cichoz-Lach H; Gonciarz M; Bielanski W; Reiter RJ; Konturek SJ
    J Pineal Res; 2009 May; 46(4):408-14. PubMed ID: 19552764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melatonin treatment improves the antioxidant status and decreases lipid content in brain and liver of rats.
    Subramanian P; Mirunalini S; Pandi-Perumal SR; Trakht I; Cardinali DP
    Eur J Pharmacol; 2007 Oct; 571(2-3):116-9. PubMed ID: 17720153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternally administered melatonin differentially regulates lipopolysaccharide-induced proinflammatory and anti-inflammatory cytokines in maternal serum, amniotic fluid, fetal liver, and fetal brain.
    Xu DX; Wang H; Ning H; Zhao L; Chen YH
    J Pineal Res; 2007 Aug; 43(1):74-9. PubMed ID: 17614838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral melatonin reduces blood coagulation activity: a placebo-controlled study in healthy young men.
    Wirtz PH; Spillmann M; Bärtschi C; Ehlert U; von Känel R
    J Pineal Res; 2008 Mar; 44(2):127-33. PubMed ID: 18289163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic actions of melatonin in cancer: possible mechanisms.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Vigoré L; Parolini D; Colciago M; Rovelli F
    Anticancer Res; 2008; 28(2B):1377-81. PubMed ID: 18505083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.